来自MSN3 分钟
These Over-The-Counter Decongestants Don't Work, FDA Says
This follows an extensive review that found the drug ineffective for treating nasal congestion. Oral phenylephrine, widely ...
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...
FDA proposes ending use of decongestant found in many cold, allergy medicines
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
Yahoo Finance3 小时
TEZSPIRE met both co-primary endpoints in the Phase III WAYPOINT trial in patients with ...
demonstrated a statistically significant and clinically meaningful reduction in the size of nasal polyps and reduced nasal congestion compared to placebo. WAYPOINT is a randomized, double-blind trial ...
FDA proposes ending use of popular decongestant present in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
KFDI30 分钟
FDA seeks to pull common but ineffective OTC cold medicine ingredient off the market
Share on Facebook Share on Twitter The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the ...
U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
EuropaWire39 分钟
Tezspire Shows Promise in Reducing Nasal Polyp Symptoms in Phase III Trial for Chronic ...
by AstraZeneca and Amgen has shown significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP), ...
Woman's World on MSN22 小时
Is Your Toothache Actually a Sinus Infection? How to Tell—and Treat It
Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...
Seeking Alpha5 小时
Amgen, AstraZeneca post Phase 3 win for nasal polyps therapy
Citing topline data from their Phase 3 WAYPOINT trial, the companies said that the antibody therapy reduced the size of nasal ...
来自MSN15 小时
FDA moves to pull popular cold and flu medicines from shelves
The FDA is proposing many popular over-the-counter cold and allergy medications be removed from store shelves. The agency says a common ingredient they share, phenylephrine, doesn’t actually relieve ...